Jimmy Zheng(@JimmyZhengMD) 's Twitter Profileg
Jimmy Zheng

@JimmyZhengMD

MD/MS and Internal Medicine Resident @StanfordMed '23. Health services and outcomes research. Prev @UCLA '16, @LEK_Consulting '18. Opinions my own.

ID:1588981808338649088

calendar_today05-11-2022 19:49:29

62 Tweets

146 Followers

162 Following

Gregg Fonarow MD(@gcfmd) 's Twitter Profile Photo

Not much has changed in AHF 🏨 weight change in the >2 decades since first reported in ADHERE

Contemporary Decongestion Strategies in Patients Hospitalized for Heart Failure: A National Community-Based Cohort Study | JACC: Heart Failure jacc.org/doi/10.1016/j.…

Alex Sandhu

Not much has changed in AHF 🏨 weight change in the >2 decades since first reported in ADHERE Contemporary Decongestion Strategies in Patients Hospitalized for Heart Failure: A National Community-Based Cohort Study | JACC: Heart Failure jacc.org/doi/10.1016/j.… @ATSandhu
account_circle
Sunny Varshney, MD(@SunnyVMD) 's Twitter Profile Photo

Congrats to Jimmy Zheng on an insightful analysis showing wide variability in contemporary ADHF decongestion strategies and outcomes - an area of needed innovation in drug and device therapies Alex Sandhu Andrew P. Ambrosy, MD Ankeet S. Bhatt, MD, MBA Anu Lala-Trindade Marat Fudim, MD MHS

jacc.org/doi/10.1016/j.…

account_circle
Robert W. Yeh MD(@rwyeh) 's Twitter Profile Photo

Astonishing results from the DanGer Shock Trial presented at and out in NEJM today.

In patients with ST-elevation MI with cardiogenic shock, Impella reduced all-cause mortality (45.8% Impella vs. 58.5% control) at 180 days.

Some thoughts on this ground breaking trial:

Astonishing results from the DanGer Shock Trial presented at #ACC24 and out in @NEJM today. In patients with ST-elevation MI with cardiogenic shock, Impella reduced all-cause mortality (45.8% Impella vs. 58.5% control) at 180 days. Some thoughts on this ground breaking trial:
account_circle
Circulation(@CircAHA) 's Twitter Profile Photo

PRO-HF Trial: Routine patient-reported outcome assessment in heart failure clinic did not lead to changes in health status at one year Alex Sandhu Stanford Department of Medicine ahajournals.org/doi/10.1161/CI…

#CircACC24 #Simpub PRO-HF Trial: Routine patient-reported outcome assessment in heart failure clinic did not lead to changes in health status at one year #AHAJournals @ATSandhu @StanfordDeptMed ahajournals.org/doi/10.1161/CI…
account_circle
Chad Weldy, MD, PhD(@ChadSWeldy) 's Twitter Profile Photo

So fun to get together with our Stanford Cardiology Translational Investigator Pathway (TIP) group! Amazing to see how this community of physician scientists thrive StanfordCVFellowship StanfordMedRes Stanford Department of Medicine

So fun to get together with our Stanford Cardiology Translational Investigator Pathway (TIP) group! Amazing to see how this community of physician scientists thrive @StanCVFellows @StanfordMedRes @StanfordDeptMed
account_circle
Charlie M. Wray, DO, MS(@WrayCharles) 's Twitter Profile Photo

A quick reflection after 2 weeks on the inpatient teaching service:

Learning to be a good doctor is the slow accumulation of marginal (daily) gains.

Said differently, learn one new thing a day and in no time you’ll be an amazing physician.

account_circle
Chris Longenecker, MD(@hivcardiodoc) 's Twitter Profile Photo

7/ The PHARM-HF project, led by VA Palo Alto HCS and Stanford Medicine, will engage rural veterans living w/ heart failure by expanding the use of pharmacist-led titration of guideline directed medical therapy. Led by Paul Heidenreich, MD. VA HSR

7/ The PHARM-HF project, led by @VAPaloAlto and @StanfordMed, will engage rural veterans living w/ heart failure by expanding the use of pharmacist-led titration of guideline directed medical therapy. Led by Paul Heidenreich, MD. @vahsrd
account_circle
Ryan O'Keefe(@ROKeefeMD) 's Twitter Profile Photo

When I was an intern, I didn't even know what GDMT stood for.

It was challenging for me to keep track of all of the heart failure medications.

There weren't any great resources to help me remember the key medications.

So I made one.

Let's go through them.

- Thread -

1/20

When I was an intern, I didn't even know what GDMT stood for. It was challenging for me to keep track of all of the heart failure medications. There weren't any great resources to help me remember the key medications. So I made one. Let's go through them. - Thread - 1/20
account_circle
Ryan Brewster, MD(@RyanBrewsterMD) 's Twitter Profile Photo

1/ 🚨 Housing is unaffordable for most resident physicians with limited institutional supports, our newest work in JAMA Network Open finds

jamanetwork.com/journals/jaman…

@TheBCRP Alex Butler Kate Michelson Jennifer Kesselheim

1/ 🚨 Housing is unaffordable for most resident physicians with limited institutional supports, our newest work in @JAMANetworkOpen finds jamanetwork.com/journals/jaman… @TheBCRP @AlexButlerMD @KateMichelson2 @DrKesselheim
account_circle
Circ: Heart Failure(@CircHF) 's Twitter Profile Photo

from Jimmy Zheng et al published in :

Early CAD testing after new onset heart failure was associated with a modest mortality reduction, potentially mediated by subsequent statin use

ahajournals.org/doi/10.1161/CI…
Stanford Medicine William Fearon

#OriginalResearch from @JimmyZhengMD et al published in #CircHF: Early CAD testing after new onset heart failure was associated with a modest mortality reduction, potentially mediated by subsequent statin use ahajournals.org/doi/10.1161/CI… #AHAJournals @StanfordMed @wfearonmd
account_circle
Alex Sandhu(@ATSandhu) 's Twitter Profile Photo

Excited our team's work on incidental CAC notification was recognized with the 2023 Hearst Health Prize! Recognition of a huge team effort w/ David Maron Fatima Rodriguez Bhavik Patel, MD MBA Bunkerhill Health Akshay Chaudhari Stanford AIMI Curt Langlotz and many more! prnewswire.com/news-releases/…

account_circle
Jimmy Zheng(@JimmyZhengMD) 's Twitter Profile Photo

HF patients are more likely to be started + titrated on GDMT when seen by nurses or pharmacists dedicated to optimizing 💊

The typical outpatient model (3-6 month visits) does not work. Low-cost, high-touch care is the way.

Alex Sandhu Paul Heidenreich

onlinejcf.com/article/S1071-…

HF patients are more likely to be started + titrated on GDMT when seen by nurses or pharmacists dedicated to optimizing 💊 The typical outpatient model (3-6 month visits) does not work. Low-cost, high-touch care is the way. @ATSandhu @paheidenreich onlinejcf.com/article/S1071-…
account_circle
Jon Ward(@RxPDX) 's Twitter Profile Photo

HF patients do better the more often they are seen/touched. This paper nicely examines the impact of nurses and pharmacists on HF patient outcomes, with patients more likely to align with GDMT onlinejcf.com/article/S1071-…

account_circle